(MedPage Today) — As reliever monotherapy for mild asthma, the inhaled corticosteroid (ICS)-formoterol combination reduced asthma attacks in children compared with a short-acting β₂-agonist (SABA), the CARE trial showed, replicating…
Source link : https://www.medpagetoday.com/meetingcoverage/ers/117672
Author :
Publish date : 2025-09-28 05:00:00
Copyright for syndicated content belongs to the linked Source.
